ABELIS BAR BERTA enters COLLPLANT BIOTECHNOLOGIES LTD with 53K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030176
Officer· VP Legal
Since Mar 2026
53K
Baseline shares
100% direct
53K
Direct ownership
2 positions
20K
Derivative underlying
1 instrument
2
Security positions
All direct
Non-Derivative Holdings2
Restricted Share Units
DirectShares owned13K
Restricted Share Units
DirectShares owned40K
Total
53K direct53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 13K | Direct |
| Restricted Share Units | 40K | Direct |
| Total | 53K | 53K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
20K
Shares owned
N/A
Exercise price
7.5
Expiration
—
Exercise window
—
Total
Underlying
20K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 7.5 | — | — | 20K | N/A |
| Total | 20K | 0.00 | ||||